Real-world Semaglutide Effectiveness on Cardio-Kidney-Metabolic Outcomes Investigated in Canadian Retrospective Cohort
Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes
Abstract
A Canadian retrospective study is evaluating real-world semaglutide use on cardio-kidney-metabolic outcomes in adults with T2D and obesity.
TitrateLab articles covering Semaglutide
Written by TitrateLab, separately from the study summarized above.
